Gotistobart Improves Survival in Squamous NSCLC After Chemotherapy | Nature Medicine
A preliminary analysis from the PRESERVE-003 trial, published this week in Nature Medicine, indicates that the investigational drug gotistobart demonstrates promising overall survival benefits compared to docetaxel in patients with ... Read More